Biohaven Announces Orphan Drug Designation Request Granted for BHV-4157 NEW HAVEN, Conn., May 25, 2016 (GLOBE NEWSWIRE) -- via PRWEB - Biohaven Pharmaceutical Holding Company Ltd. (Biohaven) announced today that the U.S. Food and Drug Administration (FDA) has granted the...